The post-immune checkpoint inhibitor era: hopes and challenges for lung cancer immunotherapy

The post-immune checkpoint inhibitor era: hopes and challenges for lung cancer immunotherapy

Xu Manyi, Hao Yue, Song Zhengbo

PDF(2286 KB)

Tumor website：www.tumorsci.org E-mail Alert

PDF(2286 KB)

Tumor ›› 2024, Vol. 44 ›› Issue (06) : 598-620. DOI: 10.3781/j.issn.1000-7431.2024.2401-0021

The post-immune checkpoint inhibitor era: hopes and challenges for lung cancer immunotherapy

{{article.zuoZhe_EN}}

Author information +

History +

HeighLight

{{article.keyPoints_en}}

Abstract

{{article.zhaiyao_en}}

Key words

QR code of this article

Cite this article

Download Citations

{{article.zuoZheEn_L}}. {{article.title_en}}. {{journal.qiKanMingCheng_EN}}. 2024, 44(06): 598-620 https://doi.org/10.3781/j.issn.1000-7431.2024.2401-0021

References

Publishing order | Descend order by publishing year | Descend order by cited within

References

{{article.reference}}

Funding

RIGHTS & PERMISSIONS

{{article.copyrightStatement_en}}

{{article.copyrightLicense_en}}

PDF(2286 KB)

Accesses

Citation

Detail

Sections

Recommended

/

〈

〉